Sun Pharmaceuticals Ltd said it received an approval from the US Food and Drug Administration (USFDA) to market generic version of anti-depressant Venlafaxine hydrochloride extended release tablets.
"The company has received 180 days marketing exclusivity," Sun Pharma said in a statement, adding that the approval is for multiple doses of strengths of 37.5mg (base), 75mg (base) and 150mg (base).
Extended release tablets use a mechanism by which the tablets dissolve slowly and release a drug over time. They are taken less frequently and keep steadier levels of drug in the blood stream.
On Friday, Sun Pharma shares ended 0.2% down at Rs1,784 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.3% down at 18,401 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
